Brief: Chromogenics Q1 EBITDA Loss Narrows To SEK 9.3 Mln

ChromoGenics AB

20/05/2021 07:33

May 20 (Reuters) - ChromoGenics AB  CHRO.ST :
    * IN Q1, ORDER INTAKE AMOUNTED TO SEK 24.7 (7.4) MILLION, AN
INCREASE OF 234 PERCENT COMPARED TO CORRESPONDING PERIOD IN
2020.
    * NET SALES FOR Q1 2021 AMOUNTED TO SEK 1.6 (5.2) MILLION,
AND
EARNINGS AMOUNTED TO SEK -10.7 (-19.5) MILLION, WHICH
CORRESPONDS TO EARNINGS PER SHARE OF SEK -1.51 (-3.51), BASIC,
INCLUDING WARRANTS (TO3) FROM UNIT ISSUE IN DECEMBER 2020
    * JAN-MAR EBITDA LOSS SEK 9.3 MILLION VERSUS LOSS SEK 17.0
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkrbw9xXk 
Further company coverage:  CHRO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))